Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14670242 | 0.79 | ALDH1A1 (0.36) | ALDH1A1TSHR | |
| SCHEMBL25846538 | 0.75 | — | — | |
| SCHEMBL25840174 | 0.75 | — | — | |
| SCHEMBL14252171 | 0.75 | — | — | |
| SCHEMBL14617059 | 0.75 | — | — | |
| SCHEMBL12660007 | 0.74 | — | — | |
| SCHEMBL7587650 | 0.71 | — | — | |
| SCHEMBL12336186 | 0.71 | — | — | |
| SCHEMBL13039773 | 0.71 | — | — | |
| SCHEMBL8532247 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7205443-B2 | reducing a hydroxy ketone in presence of ruthenium catalyst | CENTRAL GLASS COMPANY, LIMITED (JP) | 2007-04-17 | — | — | US | disclosed |
| US-20050215836-A1 | reducing a hydroxy ketone in presence of ruthenium catalyst | CENTRAL GLASS COMPANY, LIMITED (JP) | 2005-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215836-A1 | reducing a hydroxy ketone in presence of ruthenium catalyst | HSD17B7, AKR1C3, AKR1C2 | ALDH1A1 126/4885TSHR 1717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.